布黄素囊减轻了COPD相关的炎症,并调节了肠道微生物群,代谢物
Yuanyuan Li1, Jiali Chen2, Yue Xing1
1Guangzhou Medicine University,Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical, Guangzhou, China.
Frontiers in pharmacology
|April 25, 2024
概括
布黄素囊 (BFHX) 改善肺功能,并减少慢性阻塞性肺病 (COPD) 的小鼠的肺炎. 它还调节肠道微生物群,为COPD提供了一个新的治疗选择.
科学领域:
- 肺部医学 肺部医学
- 微生物组研究 微生物组研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重要的全球健康问题.
- 布黄素囊 (BFHX) 是一种在中国用于治疗COPD的传统中医药.
- 在COPD中BFHX疗效的确切机制需要进一步阐明.
研究的目的:
- 在COPD小鼠模型上研究BFHX的治疗效果.
- 探索BFHX作用的潜在机制,包括其对炎症,氧化应激和肠道微生物群的影响.
主要方法:
- 使用香烟烟雾 (CS) 和脂多糖 (LPS) 诱导了一种COPD小鼠模型.
- 用BFHX治疗小鼠,评估结果包括肺功能,肺病理和炎症标志物 (BALF细胞计数,细胞因子).
- 西方涂抹被用来评估抗氧化应激能力,16SrRNA测序分析了肠道微生物组的组成和功能.
主要成果:
- 在COPD小鼠中,BFHX治疗显著改善了肺功能,并减少了肺气.
- 通过降低炎症细胞透和细胞因子水平,BFHX抑制了肺炎.
- BFHX增强了抗氧化应激能力,并调节了肠道微生物群,改变了细菌多样性并调节了像氨酸降解这样的代谢途径.
结论:
- 通过改善肺部健康和减少炎症,BFHX证明了COPD的治疗潜力.
- 肠道微生物组在BFHX在COPD治疗中的作用机制中发挥着作用.
- BFHX代表了一种有前途的替代治疗策略来治疗COPD.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
01:26COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116